Stay updated with breaking news from Johnson And. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Bombay High Court on Wednesday set aside the orders of the Joint Commissioner & Licensing Authority, Food and Drug Administration (FDA), Maharashtra restraining Johnson & Johnson from manufacturing baby powder.
The company asked to destroy the stock of the tested batch which was found to be sub standard.
In a context where countries at times face Ebola outbreaks, vaccines are a central tool to fight the spread of the disease.
Terminal Sterilization Services Market valuation to cross US$ 30 Bn by 2032, Forecast Future Market Insights
![[Johnson & Johnson license cancellation] Consumer health and welfare top priority: Maharashtra to Bombay High Court - Vimarsana News](https://gumlet.assettype.com/barandbench%2F2022-10%2F8dc1657b-d64d-4a04-9560-05ac53130808%2F20.jpg?w=1200&auto=format%2Ccompress&ogImage=true&enlarge=true)
Health and welfare of the consumer is most important, the Maharashtra government told the Bombay High Court on Thursday justifying it decision to cancel the manufacturing license of Johnson & Johnson baby powder.